These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 377185)

  • 1. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood serum C-peptide level after arginine stimulation in the early and later stage of insulin-dependent diabetes].
    Miedzińska-Szadkowska E; Lawecki J; Symonides-Lawecka A
    Pol Arch Med Wewn; 1980 Nov; 64(5):421-9. PubMed ID: 7012801
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 7. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide immunoreactivity (CPR): a new method for studying infants of insulin-treated diabetic mothers.
    Block MB; Pildes RS; Mossabhoy NA; Steiner DF; Rubenstein AH
    Pediatrics; 1974 Jun; 53(6):923-8. PubMed ID: 4598935
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory B-cell activity in insulin dependent maturity-onset diabetic.
    Krause U; Faisst G; Cordes U; Beyer J
    Horm Metab Res; 1979 Apr; 11(4):261-5. PubMed ID: 378805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin reserve of insulin-dependent diabetics. Role of C-peptide in the hormonal balance in diabetes].
    Dauzat J; Moinade S; Gaillard G; Glanddier Y; Gachon AM
    Presse Med; 1983 Sep; 12(32):1983-7. PubMed ID: 6225101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].
    Beischer W; Raptis S; Keller L; Maas M; Beischer B; Feilen K; Pfeiffer EF
    Klin Wochenschr; 1978 Feb; 56(3):111-20. PubMed ID: 415175
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.
    Lutterman JA; Benraad TJ; van 't Laar A
    Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute insulin response to arginine of pancreatic beta-cell].
    Emoto M; Nishizawa Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():313-8. PubMed ID: 12355765
    [No Abstract]   [Full Text] [Related]  

  • 20. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.